APA Guidelines Bundle

Treatment of Patients with Schizophrenia

APA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1303678

Contents of this Issue

Navigation

Page 17 of 29

18 Treatment Antipsychotic medications: relative side effects of oral formulations Generic name Seizures Orthostasis QT prolongation First-generation antipsychotics Chlorpromazine ++ +++ +++ Fluphenazine + + ++ Haloperidol + + ++ Loxapine + ++ ++ Molindone + + ++ Perphenazine + ++ ++ Pimozide +++ + +++ Thioridazine ++ +++ +++ Thiothixene +++ + ++ Trifluoperazine + + ++ Second-generation antipsychotics Aripiprazole + + + Asenapine + ++ ++ Brexpiprazole + + ++ Cariprazine + + ++ Clozapine +++ +++ ++ Iloperidone + +++ +++ Lurasidone + + + Olanzapine ++ ++ ++ Paliperidone + ++ ++ Quetiapine ++ ++ ++ Risperidone + ++ ++ Ziprasidone + ++ +++ +=seldom; ++=sometimes; +++=often a In general, rates of sexual dysfunction parallel rates of hyperprolactinemia except where noted in comments. b Pigmentary retinopathy; high rates of sexual dysfunction; avoid use if QTc interval is >450 msec or with concomitant use of drugs that prolong the QTc interval or inhibit CYP2D6 c FDA safety alert for impulse control disorders (e.g., gambling, binge eating); may reduce hyperprolactinemia with other antipsychotics

Articles in this issue

Archives of this issue

view archives of APA Guidelines Bundle - Treatment of Patients with Schizophrenia